Lack of pharmacokinetic drug–drug interaction between ramucirumab and irinotecan in patients with advanced solid tumors

被引：0
|
作者：
Ding Wang
Fadi Braiteh
James J. Lee
Crystal S. Denlinger
Dale R. Shepard
Archana Chaudhary
Yong Lin
Ling Gao
Christopher Asakiewicz
Federico Nasroulah
Patricia LoRusso
机构：
[1] Henry Ford Hospital,
[2] Comprehensive Cancer Centers of Nevada,undefined
[3] University of Pittsburgh School of Medicine,undefined
[4] Fox Chase Cancer Center,undefined
[5] Cleveland Clinic,undefined
[6] Eli Lilly and Company,undefined
[7] Eli Lilly and Company,undefined
[8] Yale Cancer Center,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2016年 / 78卷
关键词：
Pharmacokinetics; Drug–drug interactions; Ramucirumab; Irinotecan; SN-38; FOLFIRI;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：727 / 733
页数：6
相关论文
共 50 条
  • [21] Lack of pharmacokinetic drug interaction between tenofovir disoproxil fumarate and nelfinavir mesylate
    Boffito, M
    Pozniak, A
    Kearney, BP
    Higgs, C
    Mathias, A
    Zhong, LJ
    Shah, J
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (10) : 4386 - 4389
  • [22] Co-administration of vismodegib with rosiglitazone or combined oral contraceptive in patients with locally advanced or metastatic solid tumors: a pharmacokinetic assessment of drug-drug interaction potential
    LoRusso, Patricia M.
    Piha-Paul, Sarina A.
    Mita, Monica
    Colevas, A. Dimitrios
    Malhi, Vikram
    Colburn, Dawn
    Yin, Ming
    Low, Jennifer A.
    Graham, Richard A.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (01) : 193 - 202
  • [23] Irinotecan in combination with thalidomide in patients with advanced solid tumors: a clinical study with pharmacodynamic and pharmacokinetic evaluation
    Allegrini, Giacomo
    Di Paolo, Antonello
    Cerri, Elisa
    Cupini, Samanta
    Amatori, Federica
    Masi, Gianluca
    Danesi, Romano
    Marcucci, Lorenzo
    Bocci, Guido
    Del Tacca, Mario
    Falcone, Alfredo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 58 (05) : 585 - 593
  • [24] Irinotecan in combination with thalidomide in patients with advanced solid tumors: a clinical study with pharmacodynamic and pharmacokinetic evaluation
    Giacomo Allegrini
    Antonello Di Paolo
    Elisa Cerri
    Samanta Cupini
    Federica Amatori
    Gianluca Masi
    Romano Danesi
    Lorenzo Marcucci
    Guido Bocci
    Mario Del Tacca
    Alfredo Falcone
    Cancer Chemotherapy and Pharmacology, 2006, 58 : 585 - 593
  • [25] Multiple drugsSupratherapeutic drug levels following drug-drug pharmacokinetic interaction and lack of efficacy
    Reactions Weekly, 2024, 2003 (1) : 638 - 638
  • [26] Cabazitaxel plus cisplatin coadministration and drug-interaction study in patients with advanced solid tumors
    Mita, Alain C.
    Sundaram, Shankar
    Sarantopoulos, John
    Mita, Monica M.
    Lane, Alex R.
    Moseley, Jennifer L.
    Mahalingam, Devalingam
    Tan, Benjamin R.
    Dedieu, Jean-Francois
    Stash, Diane
    Zhi, Xin
    Mazuir, Florent
    Lockhart, Albert C.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [27] Drug-Drug Interaction Between Uricosuric Agent Benzbromarone and Irinotecan
    Zhang, Tong
    Ye, Xueting
    Han, Jianbo
    Wang, Jian
    Zhao, Liang
    Ying, Guoping
    Song, Yan
    Ding, Ying
    Wang, Ling
    Liu, Junmao
    Yi, Yongxiang
    LATIN AMERICAN JOURNAL OF PHARMACY, 2017, 36 (05): : 1014 - 1018
  • [28] Lack of a pharmacokinetic drug-drug interaction between lithium and valproate when co-administered with aripiprazole
    Boulton, D. W.
    Kollia, G. D.
    Mallikaarjun, S.
    Kornhauser, D. M.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2012, 37 (05) : 565 - 570
  • [29] Pharmacokinetic drug-drug interaction study of the angiopoietin-1/angiopoietin-2-inhibiting peptibody trebananib (AMG 386) and paclitaxel in patients with advanced solid tumors
    Diamond, Jennifer R.
    Wu, Benjamin
    Agarwal, Neeraj
    Bowles, Daniel W.
    Lam, Elaine T.
    Werner, Theresa L.
    Rasmussen, Erik
    Gamelin, Erick
    Soto, Felipe
    Friberg, Greg
    Sun, Yu-Nien
    Sharma, Sunil
    INVESTIGATIONAL NEW DRUGS, 2015, 33 (03) : 691 - 699
  • [30] Pharmacokinetic drug-drug interaction study of the angiopoietin-1/angiopoietin-2-inhibiting peptibody trebananib (AMG 386) and paclitaxel in patients with advanced solid tumors
    Jennifer R. Diamond
    Benjamin Wu
    Neeraj Agarwal
    Daniel W. Bowles
    Elaine T. Lam
    Theresa L. Werner
    Erik Rasmussen
    Erick Gamelin
    Felipe Soto
    Greg Friberg
    Yu-Nien Sun
    Sunil Sharma
    Investigational New Drugs, 2015, 33 : 691 - 699
12345